McKesson Signs Agreement to Acquire Rx Savings Solutions

September 19, 2022

McKesson Corporation has signed a definitive agreement to acquire Rx Savings Solutions (RxSS), a prescription price transparency and benefit insight company focused on affordability and medication adherence for health plans and large self-funded employers. The transaction is valued up to $875 million ($600 million upfront plus up to $275 million contingent on RxSS performance through calendar year 2025) and is expected to close in the second half of fiscal 2023, subject to customary regulatory approvals. Following closing, RxSS will become part of McKesson’s Prescription Technology Solutions business.

Buyers
McKesson Corporation
Targets
Rx Savings Solutions (RxSS)
Location
Texas, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.